论文部分内容阅读
目的观察阿托伐他汀联合曲美他嗪治疗冠心病的临床效果。方法选取冠心病患者71例,随机分为观察组36例与对照组35例。对照组在常规治疗基础上予阿托伐他汀治疗,观察组在对照组基础上加用曲美他嗪治疗,比较2组临床效果及不良反应发生情况。结果观察组总有效率为88.9%,高于对照组的68.6%,观察组的治疗总有效率明显优于对照组(P<0.05)。观察组出现不良反应2例(5.6%),低于对照组的4例(11.4%)(P<0.05)。结论阿托伐他汀联合曲美他嗪治疗冠心病临床效果显著,不良反应发生率低,值得临床推广应用。
Objective To observe the clinical effect of atorvastatin combined with trimetazidine in the treatment of coronary heart disease. Methods 71 patients with coronary heart disease were randomly divided into observation group 36 cases and control group 35 cases. The control group was treated with atorvastatin on the basis of routine treatment. The observation group was treated with trimetazidine on the basis of the control group. The clinical effects and the incidence of adverse reactions in the two groups were compared. Results The total effective rate of the observation group was 88.9%, which was higher than that of the control group (68.6%). The total effective rate of the observation group was significantly better than that of the control group (P <0.05). There were 2 adverse reactions (5.6%) in the observation group and 4 cases (11.4%) in the control group (P <0.05). Conclusion Atorvastatin combined with trimetazidine treatment of coronary heart disease clinical effect is significant, the incidence of adverse reactions is low, worthy of clinical application.